http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022520798-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0491 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
| filingDate | 2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022520798-A |
| titleOfInvention | Prostate-specific membrane antigen (PSMA) ligand containing a linker capable of cleaving amylase |
| abstract | In particular, the present invention relates to a PSMA binding ligand comprising an oligosaccharide constituent block containing a binding that can be cleaved by alpha-amylase. Typically, this PSMA binding ligand further comprises a PSMA binding motif Q and a chelating agent residue A, wherein the PSMA binding motif Q and the chelating agent residue A preferably contain at least one linker comprising an oligosaccharide constituent block. Linked via AL AQ -Q, the PSMA binding ligand therefore preferably has structure (I) or a pharmaceutically acceptable salt or solvate thereof. [Selection diagram] None |
| priorityDate | 2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 177.